Jacobson Pharma Corporation Limited (HKG:2633)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.140
+0.010 (0.88%)
Apr 29, 2026, 4:08 PM HKT
-8.06%
Market Cap 2.28B
Revenue (ttm) 1.53B
Net Income (ttm) 302.58M
Shares Out 2.00B
EPS (ttm) 0.15
PE Ratio 7.50
Forward PE 8.32
Dividend 0.10 (8.63%)
Ex-Dividend Date Dec 1, 2025
Volume 86,000
Average Volume 301,326
Open 1.140
Previous Close 1.130
Day's Range 1.130 - 1.150
52-Week Range 1.110 - 1.780
Beta 0.25
RSI 29.58
Earnings Date Jun 12, 2026

About HKG:2633

Jacobson Pharma Corporation Limited, through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally. It operates in two segments, Generic Drugs and Branded Healthcare. The company offers generic drugs for various therapeutic categories, including cardiovascular, central nervous, gastrointestinal, respiratory, musculo-skeletal, genito-urinary, anti-infectives, endocrine and metabolic, dermatological, and anti-allergic. It... [Read more]

Sector Healthcare
Founded 2016
Employees 1,792
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2633
Full Company Profile

Financial Performance

In fiscal year 2025, HKG:2633's revenue was 1.58 billion, an increase of 7.43% compared to the previous year's 1.47 billion. Earnings were 300.83 million, an increase of 12.69%.

Financial Statements

News

There is no news available yet.